Publication | Closed Access

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

HypertensionUrologyRenal DiseaseRenal FunctionCardiovascular DiseaseRenal CareKidney FailureRenal OutcomesOntarget StudyMedicineRenal PharmacologyAtherosclerosisNephrologyAnesthesiologyHigh Vascular Risk